Prostate-specific membrane antigen (PSMA), which is highly expressed in normal and malignant prostate epithelial cells, is considered a tumor marker with higher specificity and sensitivity than prostate specific antigen (PSA). This evidence concerns the gene FOLH1 and neoplasm.